Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma

医学 脑膜中动脉 栓塞 血肿 外科 开颅术 随机对照试验 置信区间 不利影响 大脑中动脉 放射科 内科学 缺血
作者
Jianmin Liu,Wei Ni,Qiao Zuo,Heng Yang,Ya Peng,Zhiqing Lin,Zhenbao Li,Jiyue Wang,Yong Zhen,Jing Luo,Yuanxiang Lin,Jian Chen,Xuming Hua,Hua Lu,Ming Zhong,Mingfa Liu,Jianmin Zhang,Yang Wang,Jieqing Wan,Liang Li
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:391 (20): 1901-1912 被引量:233
标识
DOI:10.1056/nejmoa2401201
摘要

BACKGROUND: The effect of embolization of the middle meningeal artery in patients with subacute or chronic subdural hematoma is uncertain. METHODS: We performed a multicenter, open-label, randomized trial in China, involving patients with symptomatic nonacute subdural hematoma with mass effect. Patients were assigned to undergo burr-hole drainage or receive nonsurgical treatment at the surgeon's discretion, and patients in each group were then randomly assigned, in a 1:1 ratio, to undergo middle meningeal artery embolization with liquid embolic material or to receive usual care. Patients whose condition warranted craniotomy were excluded. The primary outcome was symptomatic recurrence or progression of subdural hematoma within 90 days after randomization. Secondary outcomes included clinical and imaging outcomes. The main safety outcome was any serious adverse event (including death). RESULTS: The analysis included 722 patients, of whom 360 were assigned to the embolization group and 362 to the usual-care group. Burr-hole drainage was performed in 78.3% of the enrolled patients; among the patients who underwent burr-hole drainage, the procedure occurred after embolization in 99.6%. Symptomatic recurrence or progression of subdural hematoma within 90 days occurred in 24 patients (6.7%) in the embolization group and in 36 (9.9%) in the usual-care group (between-group difference, -3.3 percentage points; 95% confidence interval, -7.4 to 0.8; P = 0.10). The incidence of serious adverse events was lower in the embolization group than in the usual-care group (6.7% vs. 11.6%, P = 0.02). CONCLUSIONS: Among patients with symptomatic nonacute subdural hematoma (of whom 78% underwent burr-hole drainage), middle meningeal artery embolization resulted in a 90-day incidence of symptomatic recurrence or progression similar to that with usual care but was associated with a lower incidence of serious adverse events. (Funded by Shanghai Shenkang Hospital Development Center and others; MAGIC-MT ClinicalTrials.gov number, NCT04700345.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cl完成签到,获得积分10
刚刚
dde发布了新的文献求助10
刚刚
renjiu完成签到,获得积分10
刚刚
Ethan完成签到,获得积分10
1秒前
星辰大海的应助被甜美柏柳采纳,获得10
1秒前
温酒完成签到,获得积分10
2秒前
QQGT完成签到,获得积分10
2秒前
子叶叶子完成签到,获得积分0
2秒前
2秒前
Au完成签到 ,获得积分10
3秒前
yoyo完成签到,获得积分10
3秒前
杨晓明完成签到,获得积分20
3秒前
hyyyg发布了新的文献求助10
4秒前
星辰大海的应助被出岫采纳,获得10
4秒前
格物完成签到,获得积分10
4秒前
5秒前
李李完成签到,获得积分10
5秒前
cbh完成签到,获得积分10
5秒前
柠檬完成签到,获得积分10
5秒前
树人完成签到,获得积分10
5秒前
科研小白完成签到,获得积分10
6秒前
卜算子完成签到,获得积分10
6秒前
疯狂的寄松完成签到,获得积分10
6秒前
6秒前
YF完成签到,获得积分10
6秒前
7秒前
7秒前
木木易完成签到 ,获得积分10
7秒前
Ping完成签到,获得积分10
7秒前
拉长的黎云关注了科研通微信公众号
8秒前
Jiali完成签到,获得积分10
8秒前
8秒前
8秒前
赘婿的应助被科研通管家采纳,获得10
8秒前
英俊的铭的应助被呜呼采纳,获得10
8秒前
ZH完成签到 ,获得积分10
8秒前
9秒前
贝木木完成签到,获得积分10
9秒前
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152226
求助须知:如何正确求助?哪些是违规求助? 9549007
关于积分的说明 21689901
捐赠科研通 7740494
什么是DOI,文献DOI怎么找? 3425145
关于科研通互助平台的介绍 2550358
邀请新用户注册赠送积分活动 2468652